445492-19-3

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
1-[(tert-Butoxy)carbonyl]-3,4-dihydro-1,8-naphthyridine-7(2H)-acetic acid is used as a potential candidate in pharmaceutical research and drug development for its possible biological and therapeutic properties. 1-[(tert-Butoxy)carbonyl]-3,4-dihydro-1,8-naphthyridine-7(2H)-acetic acid's naphthyridine structure suggests it may have applications as an antibacterial or antifungal agent, contributing to the discovery of new treatments for infectious diseases.
Used in Antibacterial Applications:
In the field of antibacterial research, 1-[(tert-Butoxy)carbonyl]-3,4-dihydro-1,8-naphthyridine-7(2H)-acetic acid is used as a potential antibacterial agent. Its naphthyridine structure may provide a foundation for the development of new antibiotics, addressing the growing need for effective treatments against resistant bacterial strains.
Used in Antifungal Applications:
Similarly, in antifungal research, 1-[(tert-Butoxy)carbonyl]-3,4-dihydro-1,8-naphthyridine-7(2H)-acetic acid is used as a potential antifungal agent. 1-[(tert-Butoxy)carbonyl]-3,4-dihydro-1,8-naphthyridine-7(2H)-acetic acid's structure may offer insights into the development of new antifungal drugs, which could be crucial in combating fungal infections and their associated health complications.

InChI:InChI=1/C15H20N2O4/c1-15(2,3)21-14(20)17-8-4-5-10-6-7-11(9-12(18)19)16-13(10)17/h6-7H,4-5,8-9H2,1-3H3,(H,18,19)

Upstream product

• 855313-30-3 2-tert-butylamino-pyridine-3-carbaldehyde 
• 243641-37-4 tert-butyl 7-methyl-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxylate 
• 274676-47-0 7-methyl-1,2,3,4-tetrahydro-[1,8]naphthyridine 
• 1569-16-0 2-methyl-[1,8]naphthyridine 
• 76293-30-6 N-tert-butyl-2-aminopyridine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 7521-41-7 2-Aminonicotinaldehyde 
• 504-29-0 2-aminopyridine 
• 243641-38-5 7-ethoxycarbonylmethyl-3,4-dihydro-2H-[1,8]naphthyridine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 445490-61-9 2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethanol 

Relevant academic research and scientific papers

Non-peptidic αvβ3 antagonists containing indol-1-yl propionic acids

We describe the synthesis and structure/activity relationship of RGD mimetics that are potent inhibitors of the integrin αvβ 3. Indol-1-yl propionic acids containing a variety of basic moieties at the 5-position, as well as substitutions alpha and beta to the carboxy terminus were synthesized and evaluated. Novel compounds with improved potency have been identified.